Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0038389992
Fri, 21.07.2023
BB BIOTECH AG
Media release as at July 21, 2023
Interim report of BB Biotech AG as at June 30, 2023
Sector rotation and fund outflows weigh on biotech stocks, but positive developments allow fund raising to strengthen industry
The first half of 2023 has been disappointing for biotech investors. A massive rotation has put biotech stocks under pressure. Whereas [ … ]
Fri, 21.07.2023
BB BIOTECH AG
Ad hoc announcement pursuant to Art. 53 LR
July 21, 2023
BB Biotech AG publishes its interim report
BB Biotech AG (ISIN CH0038389992) today published its interim report as at June 30, 2023, which covers the results of its business activities for the first six months of 2023.
Based on the consolidated accounts of BB Biotech AG, net loss for the [ … ]
Wed, 03.05.2023
BB BIOTECH AG
Expert commentary
Creating blockbuster drugs using algorithms
Artificial intelligence is becoming an increasingly important tool in the drug discovery and development process. Biotech investors benefit from this technology too.
Dr. Samuel Croset, Data Scientist BB Biotech at Bellevue Asset Management
Artificial intelligence and machine-learning [ … ]
Wed, 03.05.2023
BB BIOTECH AG
Expert commentary
Creating blockbuster drugs using algorithms
Artificial intelligence is becoming an increasingly important tool in the drug discovery and development process. Biotech investors benefit from this technology too.
Dr. Samuel Croset, Data Scientist BB Biotech at Bellevue Asset Management
Artificial intelligence and machine-learning [ … ]
Fri, 21.04.2023
BB BIOTECH AG
Ad hoc announcement pursuant to Art. 53 LR
April 21, 2023
BB Biotech AG publishes its interim report
BB Biotech AG (ISIN CH0038389992) today published its interim report as at March 31, 2023, which covers the results of its business activities for the first three months of 2023.
Based on the consolidated accounts of BB Biotech AG, net loss for [ … ]
Fri, 21.04.2023
BB BIOTECH AG
Ad hoc announcement pursuant to Art. 53 LR
April 21, 2023
BB Biotech AG publishes its interim report
BB Biotech AG (ISIN CH0038389992) today published its interim report as at March 31, 2023, which covers the results of its business activities for the first three months of 2023.
Based on the consolidated accounts of BB Biotech AG, net loss for [ … ]
Fri, 21.04.2023
BB BIOTECH AG
Media release as at April 21, 2023
Interim report of BB Biotech AG as at March 31, 2023
Lackluster first quarter for biotech stocks
Concerns about capital market resilience clearly had an impact on investor preferences during the first quarter. After a strong start to the year, market sentiment switched to risk-off and this triggered heavy sellin [ … ]
Fri, 21.04.2023
BB BIOTECH AG
Media release as at April 21, 2023
Interim report of BB Biotech AG as at March 31, 2023
Lackluster first quarter for biotech stocks
Concerns about capital market resilience clearly had an impact on investor preferences during the first quarter. After a strong start to the year, market sentiment switched to risk-off and this triggered heavy sellin [ … ]
Thu, 23.03.2023
BB BIOTECH AG
Media release of March 23, 2023
Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.85 per share
All proposals of BB Biotech AG's Board of Directors were approved by BB Biotech AG's shareholders at its Annual General Meeting held today.
Shareholders voted in favor of the proposal to pay out a divi [ … ]
Thu, 23.03.2023
BB BIOTECH AG
Media release of March 23, 2023
Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.85 per share
All proposals of BB Biotech AG's Board of Directors were approved by BB Biotech AG's shareholders at its Annual General Meeting held today.
Shareholders voted in favor of the proposal to pay out a divi [ … ]